- Home
- ERAS vs NAT Comparison
ERAS vs NAT Comparison
Compare ERAS & NAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ERAS
- NAT
- Stock Information
- Founded
- ERAS 2018
- NAT 1995
- Country
- ERAS United States
- NAT Bermuda
- Employees
- ERAS N/A
- NAT N/A
- Industry
- ERAS Biotechnology: Pharmaceutical Preparations
- NAT Marine Transportation
- Sector
- ERAS Health Care
- NAT Consumer Discretionary
- Exchange
- ERAS Nasdaq
- NAT Nasdaq
- Market Cap
- ERAS 719.0M
- NAT 641.0M
- IPO Year
- ERAS 2021
- NAT 1997
- Fundamental
- Price
- ERAS $2.67
- NAT $2.98
- Analyst Decision
- ERAS Strong Buy
- NAT Hold
- Analyst Count
- ERAS 5
- NAT 2
- Target Price
- ERAS $6.10
- NAT $3.75
- AVG Volume (30 Days)
- ERAS 1.7M
- NAT 2.7M
- Earning Date
- ERAS 11-12-2024
- NAT 11-27-2024
- Dividend Yield
- ERAS N/A
- NAT 16.11%
- EPS Growth
- ERAS N/A
- NAT N/A
- EPS
- ERAS N/A
- NAT 0.29
- Revenue
- ERAS N/A
- NAT $364,249,000.00
- Revenue This Year
- ERAS N/A
- NAT N/A
- Revenue Next Year
- ERAS N/A
- NAT $11.06
- P/E Ratio
- ERAS N/A
- NAT $10.27
- Revenue Growth
- ERAS N/A
- NAT N/A
- 52 Week Low
- ERAS $1.51
- NAT $2.95
- 52 Week High
- ERAS $3.45
- NAT $4.64
- Technical
- Relative Strength Index (RSI)
- ERAS 43.56
- NAT 30.59
- Support Level
- ERAS $2.59
- NAT $2.95
- Resistance Level
- ERAS $3.19
- NAT $3.12
- Average True Range (ATR)
- ERAS 0.20
- NAT 0.10
- MACD
- ERAS -0.02
- NAT -0.01
- Stochastic Oscillator
- ERAS 20.13
- NAT 6.10
About ERAS Erasca Inc.
Erasca Inc is a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's pipeline includes; Naporafenib, a pan-RAF inhibitor with first-in-class potential in NRASm melanoma, RAS Q61X tissue agnostic solid tumors, and other RAS/MAPK pathway-driven tumors, and ERAS-007 (oral ERK1/2 inhibitor) and ERAS-601 (oral SHP2 inhibitor), which target downstream and upstream nodes, respectively, of the RAS/MAPK pathway.
About NAT Nordic American Tankers Limited
Nordic American Tankers Ltd owns and operates double hull crude oil tankers. It is an international tanker company that owns double-hull Suezmax tankers. It operates vessels in the spot market or on spot market-related charters pursuant to cooperative arrangements with third parties. The company's fleet consists of crude oil tankers, and all of its vessels are employed in the spot market. The company has only one type of vessel - Suezmax crude oil tankers. It operates in markets that are very competitive and based mainly on supply and demand.